EventsGalileo Analytics News

Galileo Analytics Co-Founder to Speak at Johns Hopkins Digital Health Event

By May 20, 2016 No Comments

(Washington, DC – May 19, 2016) –  Galileo Analytics Co-Founder Anna McCollister-Slipp will speak next week as part of a panel discussing The Impact of Wearable Devices on Healthcare, sponsored by the Johns Hopkins University alumni association.

The panel, which is scheduled for May 24, will consider the potential good – and bad – effects of connected health devices, ranging from blood glucose meters and blood pressure meters to activity trackers and mobile apps.

In addition to McCollister-Slipp, the panel will include a range of speakers, digital health enthusiasts and experts.

More information about the event is below:

The Impact of Wearable Devices on Healthcare

May 24, 2016

6:00 pm

The Palomar Hotel

2121 P Street NW

Washington, DC 20037

Abhijit Dasgupta, PhD

Chief Data Science Officer, Zansors, LLC

Peter Celano

Director of Consumer Health Initiatives, MedStar Institute for Innovation

Anna McCollister Slipp

Chief Advocate for Participatory Research at Scripps Translational Science Institute

Co-Founder, Galileo Analytics

Douglas E. Goldstein

Nicole L. Stout (Moderator)

Health Care and health IT Consultant, Researcher, and Author

For more information about the panel, please visit: https://jhweb.dev.jhu.edu/eforms/form/WearMeDC

###

Admin

About Admin

Anna McCollister-Slipp is co-founder of Galileo Analytics, a Visual Data Exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data. In addition, she is the Chief Advocate for Participatory Research at the Scripps Translational Science Institute, where she is charged with bringing the expertise of patients, caregivers and community physicians into the design of health research. Anna’s passion for innovation in health data research is rooted in her personal experiences living with type 1 diabetes. As an entrepreneur and advocate, she speaks frequently about the promise of digital health, the imperative for patient data access and the need for improved outcomes measures for chronic disease. Anna serves on a number of government and private committees and boards aimed at promoting innovative ways to better understand, manage and treat complex health conditions, such as diabetes.

%d bloggers like this: